Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 10  •  10:00AM ET
1.00
Dollar change
-0.05
Percentage change
-4.76
%
Index- P/E- EPS (ttm)-3.54 Insider Own14.59% Shs Outstand58.89M Perf Week-35.48%
Market Cap63.21M Forward P/E- EPS next Y-0.20 Insider Trans5.13% Shs Float53.98M Perf Month-52.83%
Enterprise Value48.91M PEG- EPS next Q-0.07 Inst Own26.71% Short Float19.20% Perf Quarter-69.74%
Income54.69M P/S3.06 EPS this Y107.28% Inst Trans4.10% Short Ratio2.38 Perf Half Y-82.21%
Sales20.69M P/B0.28 EPS next Y-278.26% ROA24.95% Short Interest10.36M Perf YTD-40.48%
Book/sh3.58 P/C0.29 EPS next 5Y- ROE50.68% 52W High22.57 -95.57% Perf Year-74.49%
Cash/sh3.40 P/FCF- EPS past 3/5Y12.60% 25.24% ROIC15.40% 52W Low0.98 2.04% Perf 3Y-98.47%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-11.83% 16.36% Gross Margin75.22% Volatility14.81% 9.79% Perf 5Y-
Dividend TTM- EV/Sales2.36 EPS Y/Y TTM86.74% Oper. Margin-98.48% ATR (14)0.19 Perf 10Y-
Dividend Ex-Date- Quick Ratio3.39 Sales Y/Y TTM- Profit Margin264.27% RSI (14)24.81 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio3.41 EPS Q/Q148.51% SMA20-43.90% Beta-0.43 Target Price7.00
Payout- Debt/Eq0.95 Sales Q/Q112.09% SMA50-51.31% Rel Volume1.86 Prev Close1.05
Employees59 LT Debt/Eq0.68 EarningsFeb 10 AMC SMA200-82.52% Avg Volume4.36M Price1.00
IPOJun 24, 2021 Option/ShortYes / Yes EPS/Sales Surpr.7500.00% 0.91% Trades Volume997,089 Change-4.76%
Date Action Analyst Rating Change Price Target Change
Aug-04-25Initiated Alliance Global Partners Buy $15
Jun-16-25Upgrade Cantor Fitzgerald Neutral → Overweight $16
Feb-09-26 08:00AM
Feb-06-26 08:33AM
Jan-29-26 08:00AM
Jan-13-26 08:00AM
Jan-09-26 08:00AM
08:00AM Loading…
Jan-07-26 08:00AM
Jan-06-26 07:40PM
Dec-30-25 08:00AM
Dec-24-25 03:14AM
Dec-23-25 01:38PM
11:30AM
09:03AM
Dec-03-25 08:00AM
Dec-02-25 08:00AM
Nov-26-25 08:00AM
07:49AM Loading…
Nov-14-25 07:49AM
Nov-13-25 06:00PM
11:31AM
08:30AM
Nov-12-25 08:02PM
12:04AM
Nov-11-25 05:25PM
Nov-06-25 08:00AM
Nov-05-25 11:29AM
Nov-04-25 08:00AM
Oct-31-25 08:00AM
Oct-23-25 06:45PM
08:00AM
Oct-06-25 08:00AM
Sep-30-25 08:00AM
06:12AM Loading…
Sep-26-25 06:12AM
Sep-24-25 05:55PM
Sep-15-25 07:17PM
Sep-12-25 09:15AM
Sep-11-25 05:07PM
08:00AM
Sep-08-25 08:52AM
06:30AM
Sep-03-25 08:00AM
Aug-28-25 08:00AM
Aug-27-25 02:34PM
Aug-26-25 12:43PM
Aug-25-25 10:30AM
Aug-19-25 05:07PM
Aug-14-25 12:21PM
Aug-13-25 10:30AM
Aug-12-25 02:08PM
08:00AM
Aug-11-25 10:30AM
Aug-05-25 08:00AM
08:00AM
Jul-30-25 08:00AM
Jul-28-25 01:16PM
08:00AM
Jul-25-25 09:29AM
Jul-23-25 08:00AM
06:14AM
Jul-21-25 08:00AM
Jul-17-25 08:00AM
Jul-15-25 12:16PM
08:36AM
Jul-11-25 12:04PM
08:30AM
Jul-08-25 08:00AM
Jul-01-25 07:00AM
Jun-26-25 11:09AM
08:00AM
Jun-18-25 10:05AM
Jun-17-25 04:05PM
10:22AM
09:46AM
09:00AM
Jun-16-25 02:45PM
Jun-12-25 09:00AM
Jun-10-25 10:33AM
Jun-09-25 09:00AM
Jun-05-25 09:00AM
May-30-25 08:00AM
May-29-25 08:00AM
May-28-25 09:20AM
09:08AM
May-27-25 09:00AM
May-22-25 08:00AM
May-16-25 09:00AM
May-13-25 09:00AM
May-12-25 08:50AM
08:00AM
May-06-25 08:00AM
Apr-30-25 04:25PM
Apr-29-25 12:15PM
08:00AM
Apr-24-25 04:10PM
Apr-22-25 09:51AM
Apr-21-25 11:22AM
11:09AM
08:00AM
Feb-06-25 08:00AM
Jan-24-25 08:00AM
Jan-23-25 08:00AM
Dec-23-24 09:00AM
Upexi, Inc. engages in the development, manufacturing, and distribution of consumer products through direct-to-consumer network, wholesale partnerships, and major third-party platforms like Amazon. Its brands include LuckyTail, Prax, Cure Mushrooms, Moonwlkr, and Gumi Labs. The company was founded on September 5, 2018 and is headquartered in Tampa, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MARSHALL ALLANChief Executive OfficerDec 23 '25Buy1.8050,00090,0004,046,261Dec 23 07:53 PM
MARSHALL ALLANChief Executive OfficerDec 15 '25Buy2.07100,000207,0003,946,261Dec 17 06:43 PM
MARSHALL ALLANChief Executive OfficerDec 16 '25Buy2.0750,000103,5003,996,261Dec 17 06:43 PM
Salkind GeneDirectorNov 20 '25Buy2.5550,000127,500218,750Nov 21 06:32 AM
Salkind GeneDirectorNov 17 '25Buy2.81100,000281,000168,750Nov 18 09:40 PM
Salkind GeneDirectorNov 17 '25Buy2.65100,000265,000569,470Nov 18 09:40 PM
Salkind GeneDirectorJul 11 '25Buy4.9420,243100,000385,370Jul 30 04:47 PM
Dugan LawrenceDirectorJul 16 '25Buy5.6911,00062,600112,389Jul 24 04:05 PM
Dugan LawrenceDirectorJul 22 '25Buy7.504,00030,000116,389Jul 24 04:05 PM
Dugan LawrenceDirectorJul 15 '25Buy5.171,0005,1701,389Jul 24 04:05 PM
MARSHALL ALLANChief Executive OfficerJul 11 '25Buy4.94161,943799,9981,046,261Jul 24 04:03 PM
MARSHALL ALLANChief Executive OfficerApr 17 '25Buy2.28657,8951,500,001809,318Apr 25 04:01 PM
Norstrud Andrew JamesChief Financial OfficerApr 17 '25Buy2.2843,860100,00159,138Apr 25 04:01 PM
Salkind GeneDirectorApr 17 '25Buy2.28241,229550,002365,127Apr 25 04:01 PM